These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9458763)

  • 1. Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion.
    Watanabe RM; Steil GM; Bergman RN
    Am J Physiol; 1998 Jan; 274(1):E172-83. PubMed ID: 9458763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prehepatic beta-cell secretion during the intravenous glucose tolerance test in humans: application of a combined model of insulin and C-peptide kinetics.
    Watanabe RM; Volund A; Roy S; Bergman RN
    J Clin Endocrinol Metab; 1989 Oct; 69(4):790-7. PubMed ID: 2674187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion.
    Toffolo G; De Grandi F; Cobelli C
    Diabetes; 1995 Jul; 44(7):845-54. PubMed ID: 7789653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate measurement of endogenous insulin secretion does not require separate assessment of C-peptide kinetics.
    Watanabe RM; Bergman RN
    Diabetes; 2000 Mar; 49(3):373-82. PubMed ID: 10868958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods.
    Kjems LL; Vølund A; Madsbad S
    Diabetologia; 2001 Oct; 44(10):1339-48. PubMed ID: 11692185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current approaches to measurement of insulin secretion.
    Polonsky KS; Rubenstein AH
    Diabetes Metab Rev; 1986; 2(3-4):315-29. PubMed ID: 3527618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics.
    Vølund A; Polonsky KS; Bergman RN
    Diabetes; 1987 Oct; 36(10):1195-202. PubMed ID: 2888696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of methods for measurement of insulin secretion in humans in vivo.
    Kjems LL; Christiansen E; Vølund A; Bergman RN; Madsbad S
    Diabetes; 2000 Apr; 49(4):580-8. PubMed ID: 10871195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.
    Van Cauter E; Mestrez F; Sturis J; Polonsky KS
    Diabetes; 1992 Mar; 41(3):368-77. PubMed ID: 1551497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism.
    O'Meara NM; Blackman JD; Sturis J; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):79-84. PubMed ID: 8421108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin minimal model indexes and secretion: proper handling of uncertainty by a Bayesian approach.
    Magni P; Sparacino G; Bellazzi R; Toffolo GM; Cobelli C
    Ann Biomed Eng; 2004 Jul; 32(7):1027-37. PubMed ID: 15298440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated mathematical model to assess beta-cell activity during the oral glucose test.
    Thomaseth K; Kautzky-Willer A; Ludvik B; Prager R; Pacini G
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E522-31. PubMed ID: 8638701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT.
    Tura A; Ludvik B; Nolan JJ; Pacini G; Thomaseth K
    Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E966-74. PubMed ID: 11595652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mathematical model of insulin secretion.
    Shannon AG; Hogg JM; Ollerton RL; Luzio S; Owens DR
    IMA J Math Appl Med Biol; 1994; 11(4):245-66. PubMed ID: 7714402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics.
    Cobelli C; Pacini G
    Diabetes; 1988 Feb; 37(2):223-31. PubMed ID: 3292317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice.
    Ahrén B; Thomaseth K; Pacini G
    Diabetologia; 2005 Oct; 48(10):2140-6. PubMed ID: 16132949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical modelling of changes in circulating insulin and C-peptide concentrations.
    Malaisse WJ; Scholler Y
    Acta Diabetol Lat; 1985; 22(2):127-37. PubMed ID: 3907230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models.
    Tura A; Pacini G; Kautzky-Willer A; Gastaldelli A; DeFronzo RA; Ferrannini E; Mari A
    Metabolism; 2012 Mar; 61(3):434-43. PubMed ID: 21944265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.
    Polonsky KS; Pugh W; Jaspan JB; Cohen DM; Karrison T; Tager HS; Rubenstein AH
    J Clin Invest; 1984 Nov; 74(5):1821-9. PubMed ID: 6389599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The limitations to and valid use of C-peptide as a marker of the secretion of insulin.
    Polonsky K; Frank B; Pugh W; Addis A; Karrison T; Meier P; Tager H; Rubenstein A
    Diabetes; 1986 Apr; 35(4):379-86. PubMed ID: 3514322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.